Flagship and GSK announce a strategic collaboration to discover and develop a portfolio of novel medicines and vaccines, starting in respiratory and immunology. Read the full announcement about our latest Innovation Supply Chain Partnership which will leverage GSK’s disease expertise and development capability together with Flagship’s ecosystem of pioneering bioplatforms: https://bit.ly/4d0aed8
Flagship Pioneering
Biotechnology Research
Cambridge, MA 95,880 followers
We are a biotechnology company that invents and builds platform companies that change the world.
About us
Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple transformative human health and sustainability products. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures. The current Flagship ecosystem comprises over 40 companies, including Denali Therapeutics, Foghorn Therapeutics, Generate:Biomedicines, Inari, Indigo Agriculture, and Tessera Therapeutics.
- Website
-
http://www.flagshippioneering.com
External link for Flagship Pioneering
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Cambridge, MA
- Type
- Privately Held
- Founded
- 2000
- Specialties
- life sciences, biotech, therapeutics, diagnostics, sustainability, climate change, artificial intelligence, machine learning, agtech, medicines, therapeutics, biology, entrepreneurship, biotechnology, science, innovation, and ventures
Locations
-
Primary
55 Cambridge Parkway
Suite 800E
Cambridge, MA 02142, US
Employees at Flagship Pioneering
-
Karim Lakhani
Professor Harvard Business School | Chair D^3 Institute at Harvard | Board Member, Mozilla Corporation & VideaHealth | Academic Partner, Flagship…
-
Venu Nagali
Strategy, Business Development & Finance Executive ✦ Increase Enterprise Value through Innovative Strategies and Building Results-Producing Teams
-
Susan Vidal
Strategic HR Leader & Employee Retention Evangelist
-
David Khougazian
Growth Partner at Flagship Pioneering
Updates
-
Congrats to CFO of #FlagshipFounded Generate:Biomedicines Jason Silvers on being recognized at Boston Business Journal’s 2024 CFO of the Year awards.
Last week, Jason Silvers, our CFO, was recognized at the Boston Business Journal's 2024 CFO of the Year awards. This accolade honors chief financial officers who have significantly impacted their organizations and the broader economy. In an interview with the Boston Business Journal, Jason discusses his career shifts from medicine to law to finance. He highlights how these experiences have equipped him to lead our financial strategies effectively, particularly in challenging market conditions. The interview offers a glimpse into his professional perspective and decision-making process. Don't miss the full interview 👇 #TeamGenerate | #AudaciouslyAmbitious
-
Our recently announced partnership with GSK will develop a portfolio of entirely new medicines and vaccines to address unmet needs initially focused in respiratory and immunology. For more on how the partnership will leverage the strengths of GSK and Flagship’s ecosystem of pioneering platforms, read this Fierce Biotech piece by James Waldron: https://lnkd.in/eBCfA6Ea
GSK becomes Flagship's latest partner in $7B biobucks respiratory, immunology pact
fiercebiotech.com
-
Hear from Volker Herrmann, MD, Flagship CEO-Partner and CEO of #FlagshipFounded Sonata Therapeutics, on how Sonata is pioneering Network Medicines™ that reprogram diseased cells to become the coordinators of cure, Sonata's approach to drug discovery, and what hobbies keep him busy outside of work.
-
“In everything we do, we are the inventors and the entrepreneurs.” Noubar Afeyan sat down with William Alpert of Barron's to discuss Flagship’s recent fund raise and how it will drive our work to develop new bioplatforms across human health and sustainability. For more on Flagship’s approach to innovation including how we are using AI to fuel bigger leaps in drug discovery, read the full article: https://bit.ly/46lJWzj
This Biotech Risk-Taker Created Moderna. Now He's Harnessing AI.
barrons.com
-
Flagship Pioneering reposted this
Today, ADI and Flagship Pioneering announced a strategic partnership to accelerate the development of a fully digitized biological world. The new partnership will bridge ADI’s expertise in engineering for analog and digital semiconductors with Flagship’s expertise in applied biology to foster the discovery of biological insights, new and enhanced measurements, diagnostics, and novel interventions. Find the full announcement here: https://ow.ly/1ThF50SK3F8 📸: ADI CEO and Chair Vincent Roche and Flagship Pioneering Founder and CEO Noubar Afeyan on stage during ADI's General Technical Conference.
-
#FlagshipFounded Cellarity welcomes Percy Carter to the company’s Board of Directors.
We're thrilled to announce that we've appointed Percy Carter, MBA, Ph.D., to our Board of Directors! Dr. Carter has a strong track record of shaping and leading drug discovery and platform development. His leadership will help accelerate our work to bring value to patients via novel biology and differentiated drug candidates. Welcome, Percy!
Cellarity Appoints Percy Carter, MBA, Ph.D., as Member of Board of Directors
businesswire.com
-
Flagship Pioneering reposted this
Introducing Abiologics - a company reimagining biologics. As a Flagship Pioneering company, we're leveraging cutting-edge generative AI and high-throughput chemical protein synthesis to create Synteins™ — a new class of supranatural and programmable medicines that transcend the limitations of nature to redefine what therapeutics can achieve for patients. Check out our approach to creating programmable medicines: https://bit.ly/46hfTsE #biotechnology #drugdiscovery #startup #FlagshipFounded
-
Flagship and Analog Devices announce a strategic partnership to accelerate the development of a fully digitized biological world, leveraging expertise in applied biology and engineering to create and enhance digital biology platform companies. Read the full announcement: https://bit.ly/46gim6N
-
Learn more about what it’s like to work at Pioneering Medicines, Flagship’s in house drug discovery and development unit, in this employee spotlight featuring Brian Bouchard, who shares why he joined the team at Pioneering Medicines and how collaboration across the Flagship ecosystem enables us to make medicines for patients sooner. See open roles on the Pioneering Medicines team: https://bit.ly/3VDclNC
"We get to leverage incredible talent and expertise at Flagship Pioneering and across the ecosystem, which allows us to continuously improve as opposed to reinventing the wheel. With that operational efficiency, the amount of work we can accomplish for our size is astonishing and it means we can move fast to make medicines that benefit patients sooner." ➡ Read more about Brian Bouchard, Sr. Manager, Laboratory Operations at Pioneering Medicines, including his role in ensuring our growing lab footprint can support our ecosystem today and in the years to come. The latest installment in our 🌟employee spotlight series🌟, introducing you to the team members that are working tirelessly to improve human health and the sustainability of our planet. #WeAreFlagship